Prosthodontic management of a patient with ameloblastoma of the lower jaw with implants Authors: Vivek Lath, Sansriti Tiwari, Fiza Qureshi Ahmed, Vaibhav Tiwari, Swati Rupam Published: 2024 ABSTRACT Mandibular ameloblastoma are rare, noncancerous tumors which originate from odontogenic epithelium. Ameloblastoma, commonly occurring in the mandible, disturbs its balance and symmetry. Surgical treatment of ameloblastoma though gets rid a patient of the tumour, but it may also result in compromised esthetics and function. The present case report focuses on the implant-supported rehabilitation of the mandibular region treated with surgical enucleation of the tumour. INTRODUCTION Mandibular ameloblastoma is a rare, noncancerous tumor which originates from odontogenic epithelium. First documented by Broca as adamantinoma in 1868 and later renamed by Churchill in 1934. It represents 1% of all jaw tumors. These tumors typically occur in individuals aged between 30 and 50 years and affect both males and females equally.[12] Histologically, there are six recognized types of mandibular ameloblastoma.[3] Various benign growths can cause swellings in the mandible, and these can be categorized as odontogenic or nonodontogenic in origin. Examples of these lesions comprise ameloblastoma, keratocystic odontogenic tumor, radicular and dentigerous cyst, central giant cell granuloma, and osteomas.[4] It is crucial for healthcare providers to be able to differentiate between these lesions for accurate diagnosis and appropriate treatment. Ameloblastoma is the most frequent tumor that originates from dental tissues and epithelial cell elements during different stages of growth. This neoplasm grows slowly, persists for a long time, and shows aggressive behavior locally. Often, it is linked with a third molar that has not erupted.[2] CASE REPORT In a dental hospital in Chhattisgarh, a 25-year-old male patient came with a chief complaint of pain in his lower right back region of the jaw from the past 7 days. Upon oral examination, #44 and #45 were tender on percussion, and there was Grade I mobility with #45. Radiographic examination revealed a large periapical cystic lesion with respect to #43, 44, 45, and 46. On histopathological examination, the diagnosis was confirmed to be mandibular ameloblastoma. Apart from this, the patient did not have any systemic disease nor did he have any habit of smoking or drinking alcohol. Following a thorough anesthesiological examination and preoperative evaluations, a surgical procedure for tumor removal was planned. Blood investigations were within normal limits. The case was managed by surgical enucleation with curettage and peripheral ostectomy [Figure 1]. Right inferior alveolar nerve and mental nerve blocks were given under 2% lignocaine with 1:200,000 adrenaline local anesthesia. A crevicular incision with no. 15 surgical blade was given. Reflection of the flap was done from the distal half of #42 to the mesial half of #47. Once the lesion was visible, it was slowly separated from the bone using Moon’s probe against the bony wall. Extreme care was taken to preserve the mandibular nerve. The lesion was removed in toto, followed by careful curettage. Thorough irrigation with betadine and saline was done, and Ab Gel was placed. Water-tight primary closure with 3-0 silk suture material was achieved. The patient’s vitals were checked and were found to be normal. Pressure pack was given, and the patient was then discharged. Preoperative orthopantomogram (ameloblastoma with the lower right back region of jaw involving 43, 44, 45, and 46) A dental implant placement procedure was conducted after the complete healing of the extracted site. Healing of the surgical site allowed the precise planning based on the exact assessment of bone formed and the surrounding tissue covering it. A year following the initial surgery at dental hospital in Chhattisgarh, a comprehensive study of alternative rehabilitation options and a detailed evaluation of postoperative functionality were performed, taking into account the patient’s needs and expectations. This led to the decision to insert endosseous implants. Initially, the patient exhibited partial edentulism in regions 43, 44, 45, and 46. Treatment planning was followed as such [Flowchart 1]. Sequence of events describing implant-supported rehabilitation of the patient Radiographic evaluation after 1 year revealed: Healing with bone formation at the defect siteAbsence of radiolucency at the surgical site. Healing with bone formation at the defect site Healing with bone formation at the defect site Absence of radiolucency at the surgical site. Absence of radiolucency at the surgical site. Prosthetic rehabilitation was carried out, as described below: The final rehabilitation was scheduled 12 months, postsurgeryTwelve months, postsurgery evaluation showed clinically healthy tissues, with no signs of tumor recurrence or inflammation [Figure 2]After a thorough evaluation with the help of panoramic radiograph and cone-beam computed tomography (CBCT), the surgical site was found to be ready for reconstruction with implants [Figure 3].During the surgical procedure for implant placement, both extraoral and intraoral antisepsis were performed, and local anesthesia was administeredCrevicular incision with no. 15c surgical blade was given in the specified region and extended along the bone crestFollowing the incision, a full-thickness mucoperiosteal flap was elevated with Molt periosteal elevator. The final rehabilitation was scheduled 12 months, postsurgery The final rehabilitation was scheduled 12 months, postsurgery Twelve months, postsurgery evaluation showed clinically healthy tissues, with no signs of tumor recurrence or inflammation [Figure 2] Twelve months, postsurgery evaluation showed clinically healthy tissues, with no signs of tumor recurrence or inflammation [Figure 2] After a thorough evaluation with the help of panoramic radiograph and cone-beam computed tomography (CBCT), the surgical site was found to be ready for reconstruction with implants [Figure 3].During the surgical procedure for implant placement, both extraoral and intraoral antisepsis were performed, and local anesthesia was administeredCrevicular incision with no. 15c surgical blade was given in the specified region and extended along the bone crestFollowing the incision, a full-thickness mucoperiosteal flap was elevated with Molt periosteal elevator. After a thorough evaluation with the help of panoramic radiograph and cone-beam computed tomography (CBCT), the surgical site was found to be ready for reconstruction with implants [Figure 3]. During the surgical procedure for implant placement, both extraoral and intraoral antisepsis were performed, and local anesthesia was administered During the surgical procedure for implant placement, both extraoral and intraoral antisepsis were performed, and local anesthesia was administered Crevicular incision with no. 15c surgical blade was given in the specified region and extended along the bone crest Crevicular incision with no. 15c surgical blade was given in the specified region and extended along the bone crest Following the incision, a full-thickness mucoperiosteal flap was elevated with Molt periosteal elevator. Following the incision, a full-thickness mucoperiosteal flap was elevated with Molt periosteal elevator. Twelve-month follow-up revealing bone healing in the affected region of the mandible suitable for implant placement Tracing of the mandibular canal was done in the CBCT scan before placement of dental implants. Evaluation of bone height and width of bone was done [Figure 3a–d]. Suitable implants were then selected and placed [Figure 4]. (a) Cone-beam computed tomography (CBCT) of the defect site after a year (defect site labelled with black arrows); (b) CBCT for implant planning in the region with 45; (c) CBCT for implant planning in the region with 43 and 44; (d) CBCT for implant planning in the region with 46 Postoperative orthopantomogram: Implant placement in the lower jaw affected by ameloblastoma Postimplant healing, a thick and keratinized gingival collar all around the implants was seen [Figure 5]. Impressions were made and prosthesis was fabricated. Well-keratinized thick gingival collar all around the implant The esthetic of the prosthesis was given due consideration. Pink porcelain mimicking the gingiva was added on the buccal side of the prosthesis to give it a natural esthetic look [Figure 6]. One-year follow-up revealed healthy tissues around the prosthesis without any signs of recurrence of the lesion [Figure 7]. Final prosthesis in occlusion on model (a) buccal view; (b) occlusal view; (c and d) intraoral placement of the prosthesis Pre- and postoperative orthopantomogram (OPG) (a) preoperative OPG; (b) 1-year postfinal prosthesis DISCUSSION Ameloblastomas are aggressive-benign tumors of epithelial origin with varying sources of origin.[5] Their clinical behavior, falling between benign and malignant, presents treatment challenges due to their high recurrence rates. These tumors exhibit a range of biological behaviors, from cystic expansion to aggressive infiltration into adjacent tissues.[6] Ameloblastomas are circumscribed by a continuous basement membrane, which tends to expand their compartment volumes into surrounding tissue spaces.[7] This unique architectural pattern means that the tumor borders in the cancellous bone extend beyond what is visible macroscopically and radiographically.[6] Research on their growth in relation to the inferior alveolar nerve has yielded conflicting findings. Some studies suggest that ameloblastomas can invade the mandibular canal, while others have not observed invasion into the nerve sheath or nerve itself. Some studies, such as those by Wu TC et al., suggest that ameloblastomas nearby or in proximity to the mandibular canal can invade and destroy the canal.[8] Conversely, Nakamura et al. reported that there was no breaching into the nerve or nerve sheath.[6] The study of Hong et al. highlighted the significant association between ameloblastoma histopathology and recurrence rates. A recurrence rate of 4.5% was found in their retrospective examination of 239 individuals with ameloblastomas after treatment with segmental resection or maxillectomy. This percentage rose to 29.3% following conservative treatment techniques such as curettage, enucleation, and marsupialization, and to 11.6% following marginal resection. The study discovered a statistically significant relationship between the recurrence rate and the treatment approach.[9] The recurrence rate of enucleation alone was 30.5%, but the recurrence rate of marsupialization was 18%. Carnoy’s solution applied in conjunction with enucleation produced a 16% recurrence rate. In contrast, the lowest recurrence rate of 3.6% was found by performing resection. The higher recurrence rates in more conservative treatments can be explained primarily by the inadequate removal of the cystic lining of the tumor. This inadequate removal leaves residual tumor cells that can lead to recurrence.[10] Therefore, understanding the biological behavior and proper surgical approach is crucial in managing ameloblastomas effectively to minimize recurrence and ensure better patient outcomes. Studies have shown varying degrees of satisfaction and limitations among patients who undergo mandibular reconstruction with dental implants. Leung and Cheung found that although the majority of patients were pleased with the repair of their soft tissues and bones following tumor ablation, only 32.1% of patients could eat the food of any consistency, and 28.6% reported experiencing instability with their prostheses.[11] Leung and Cheung found that although the majority of patients were pleased with the repair of their soft tissues and bones following tumor ablation, only 32.1% of patients could eat the food of any consistency, and 28.6% reported experiencing instability with their prostheses.[11] Leung and Cheung found that although the majority of patients were pleased with the repair of their soft tissues and bones following tumor ablation, only 32.1% of patients could eat the food of any consistency, and 28.6% reported experiencing instability with their prostheses.[11] Treatment planning for ameloblastomas should take into account patient characteristics, tumor features, and potential treatment-related morbidity. Two types of implant-supported prostheses can be considered in such cases: fixed prostheses supported by implants, which minimize oral mucosa contact and reduce the risk of ulcers, or implant-supported denture-type prostheses with a design that facilitates better hygiene maintenance. The results of this case report, which show that implants are retained over an extended length of time, validate the efficacy of using a mix of surgical and prosthetic techniques to treat and restore maxillofacial defects, i.e., ameloblastoma with implant. Furthermore, this case report underscores the potential benefits of utilizing multiple surgical techniques to achieve favorable esthetics and functionality for patients requiring posttumor removal.[1213] CONCLUSION Rehabilitation of odontogenic tumors such as ameloblastoma is always a challenge, and with the advances in treatment modalities, osseointegrated implants offer a new approach to treatment that can improve patients’ quality of life, aid in mastication, and enhance esthetics, giving back the patient their lost confidence. Dental implants are essential for providing oral prostheses in case of missing and resected region, keeping in view, the patient’s age, medical history, and level of radiation therapy. These factors can have a significant impact on the implants’ healing and survival rates. Dental implants are essential for providing oral prostheses in case of missing and resected region, keeping in view, the patient’s age, medical history, and level of radiation therapy. These factors can have a significant impact on the implants’ healing and survival rates. Dental implants are essential for providing oral prostheses in case of missing and resected region, keeping in view, the patient’s age, medical history, and level of radiation therapy. These factors can have a significant impact on the implants’ healing and survival rates. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Conflicts of interest There are no conflicts of interest.